Literature DB >> 8554559

Lactacystin, a specific inhibitor of the proteasome, induces apoptosis in human monoblast U937 cells.

S Imajoh-Ohmi1, T Kawaguchi, S Sugiyama, K Tanaka, S Omura, H Kikuchi.   

Abstract

Lactacystin, originally isolated from a microbe as an inducer of neuritogenesis, targets the catalytic beta-subunit of the proteasome, and arrests the cell cycle. Here we report for the first time that lactacystin induces apoptotic cell death in human monoblastic U937 cells. When U937 cells were cultured with lactacystin, their nuclei were shrunken, a morphological change typical of apoptosis, and cell viability was decreased. Electrophoretic analysis revealed that chromosomal DNAs from lactacystin-treated cells were cleaved in an internucleosomal ladder-like pattern, indicating that cell death occurs through an apoptotic process, which was also confirmed by DNA fragmentation analysis using flow cytometry. These findings suggest that inhibition of the proteasome during proliferation results in apoptotic cell death, and that the proteasome is a key enzyme in the course of the cell cycle that destines the cell to proliferate, differentiate or die.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8554559     DOI: 10.1006/bbrc.1995.2878

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  41 in total

Review 1.  Prosomes (proteasomes) changes during differentiation are related to the type of inducer.

Authors:  J P Bureau; L Henry; A Baz; K Scherrer; M T Château
Journal:  Mol Biol Rep       Date:  1997-03       Impact factor: 2.316

2.  Inhibition of ubiquitin-proteasome pathway activates a caspase-3-like protease and induces Bcl-2 cleavage in human M-07e leukaemic cells.

Authors:  X M Zhang; H Lin; C Chen; B D Chen
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

3.  Apoptosis in Schwann cell cultures is closely interrelated with the activity of the ubiquitin-proteasome proteolytic pathway.

Authors:  L A Pasquini; M Besio Moreno; M Lopez Salon; E F Soto
Journal:  Neurochem Res       Date:  2002-11       Impact factor: 3.996

Review 4.  The 26 S proteasome: from basic mechanisms to drug targeting.

Authors:  Ami Navon; Aaron Ciechanover
Journal:  J Biol Chem       Date:  2009-10-07       Impact factor: 5.157

5.  A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.

Authors:  Christiane B de Araujo; Lilian C Russo; Leandro M Castro; Fábio L Forti; Elisabete R do Monte; Vanessa Rioli; Fabio C Gozzo; Alison Colquhoun; Emer S Ferro
Journal:  J Biol Chem       Date:  2014-04-24       Impact factor: 5.157

6.  Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1.

Authors:  O Schwartz; V Maréchal; B Friguet; F Arenzana-Seisdedos; J M Heard
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

7.  Proteasomes play an essential role in thymocyte apoptosis.

Authors:  L M Grimm; A L Goldberg; G G Poirier; L M Schwartz; B A Osborne
Journal:  EMBO J       Date:  1996-08-01       Impact factor: 11.598

8.  Activation of the cell death program by inhibition of proteasome function.

Authors:  H C Drexler
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-04       Impact factor: 11.205

9.  Inhibition of etoposide-induced apoptosis with peptide aldehyde inhibitors of proteasome.

Authors:  C Stefanelli; F Bonavita; I Stanic; C Pignatti; G Farruggia; L Masotti; C Guarnieri; C M Caldarera
Journal:  Biochem J       Date:  1998-06-15       Impact factor: 3.857

10.  Discovery of novel proteasome inhibitors using a high-content cell-based screening system.

Authors:  Irena Lavelin; Avital Beer; Zvi Kam; Varda Rotter; Moshe Oren; Ami Navon; Benjamin Geiger
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.